FDA Approves Valneva’s Chikungunya Vaccine For Adults

Reuters (11/9, Satija, Santhosh, Jain) reports, “The U.S. Food and Drug Administration (FDA) on Thursday approved Valneva’s single-shot vaccine for individuals 18 years of age and older who are at increased risk of exposure to the chikungunya virus.” The...